RARbeta1': primed to fight retinoid resistance in lung carcinogenesis.
Open Access
- 16 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 97 (22) , 1632-1633
Abstract
Retinoids (vitamin A and its natural and synthetic analogues) have a strong preclinical record of anticarcinogenic activity in a broad range of tissue types ( 1 ) . The promise of this record, however, has not been realized in clinical trials of retinoids in preventing lung cancers. The inability of retinoids to prevent second primary lung cancers in the phase III European Study on Chemoprevention with Vitamin A and N -Acetylcysteine (EUROSCAN) ( 2 ) and the Lung Intergroup Trial (LIT) ( 3 ) has substantially dampened the enthusiasm for further exploring retinoids for lung cancer treatment and prevention. The provocative article by Petty et al. ( 4 ) on a new retinoid receptor and retinoid resistance in lung cancer lights a spark that may help to rekindle interest in retinoids for cancer chemoprevention.Keywords
This publication has 13 references indexed in Scilit:
- A Novel Retinoic Acid Receptor β Isoform and Retinoid Resistance in Lung CarcinogenesisJNCI: Journal of the National Cancer Institute, 2005
- Advances in the Biology of Lung Cancer ChemopreventionJournal of Clinical Oncology, 2005
- Increased Retinoic Acid Receptor-β4 Correlates In vivo with Reduced Retinoic Acid Receptor-β2 in Esophageal Squamous Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2005
- RETINOIC ACID RECEPTORS AND CANCERSAnnual Review of Nutrition, 2004
- P-126 Lung tumorigenesis in transgenic mice expressing RARbeta1 and RARbeta3 antisens mRNALung Cancer, 2003
- Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor- Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled TrialJNCI: Journal of the National Cancer Institute, 2003
- Retinoic Acid Receptor and Telomerase Catalytic Subunit Expression in Bronchial Epithelium of Heavy SmokersJNCI: Journal of the National Cancer Institute, 2003
- EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung CancerJNCI: Journal of the National Cancer Institute, 2000
- RARβ2 specificity in mediating RA inhibition of growth of lung cancer-derived cellsLung Cancer, 2000
- Retinoic Acid Receptor β2 (RARβ2) Null Mutant Mice Appear NormalDevelopmental Biology, 1994